Development of an engineered human enzyme for anti-vasculature immunotherapy
The tumour vasculature is an attractive target for cancer therapy because tumour growth and spread depend on these structures for oxygen and nutrient supply. Anti-vasculature therapy aims to cause rapid and selective shutdown of the established tumour vasculature, leading to secondary tumour cell de...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.539267 |